Abstract
Purpose: The optimal management of completion thyroidectomy after the unexpected diagnosis of misdiagnosed thyroid cancer by means of morbidity and indication.
Materials and methods: 30 patients with unexpected diagnosis of thyroid cancer who received completion thyroidectomy were retrospectively reviewed from 2002 to 2005. Rate of residual misdiagnosed cancer and postoperative early and late complications were evaluated.
Results: We reviewed the records of 30 patients who underwent completion thyroidectomy because of unexpected diagnosis of well differentiated thyroid cancer. 23 of the patients were women and 7 men with a median age of 49.5 (19 – 75). Residual malignancy was found in 9 patients (30%) after completion thyroidectomy and four patients had lymph node metastases. In seven patients (23.3%) the malignancy was localized in the contralateral lobe. The postoperative morbidity in completion thyroidectomy consisted of transient hypoparathyroidism in five patients (16.6%) (Ca<8mg/dl) and in one patient permanent hypoparathyroidism (longer than 6 months). There was no recurrent laryngeal nerve palsy.
Conclusion: For misdiagnosed well differentiated thyroid cancers completion thyroidectomy can be done safely with acceptable morbidity.
Keywords:
Well differentiated thyroid cancer, completion thyroidectomy, complications of thyroidectomy, thyroidectomy
References
1Hundahl SA, Cady B, Cunningham MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. Cancer, 2000; 89: 202–217.
2Shaha AR, Gleich L, DiMaio T, et al. Accuracy and pitfalls of frozen section during thyroid surgery. J Surg Oncol, 1990; 44: 84–92.
3Chao T, Jeng L, Lin J, et al. Completion thyroidectomy for differentiated thyroid carcinoma. Otolaryngol Head Neck Surg, 1998; 118: 896–899.
4Jossart GH, Clark OH. Well differentiated thyroid cancer. Curr Probl Surg, 1994; 31: 935–1011.
5Eroglu A, Unal M, Kocaoglu H. Total thyroidectomy for differentiated thyroid carcinoma: primary and secondary operations. Eur J Surg Oncol, 1998, 24: 283-287.
6Kebebew E, Clark OH. Differentiated thyroid cancer: “complete” rational approach. World J Surg, 2000, 24: 942-951.
7Kupferman ME, Mandel SJ, DiDonato L, et al. Safety of completion thyroidectomy following unilateral lobectomy for well-differentiated thyroid cancer. Laryngoscope, 2002, 112: 1209-1212.
8Clark OH, Levin K, Zeng QH, et al. Thyroid cancer: the case for total thyroidectomy. Eur J Cancer Clin. Oncol, 1988, 24: 305-313.
9Hamming JF, Van de Velde CJ, Goslings BM. Prognosis and morbidity after total thyroidectomy for papillary, follicular and medullary thyroid cancer. Eur J Cancer Clin Oncol, 1989, 25: 1317-1323.
10Hay ID, Grant CS, Taylor WF. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma. Surgery, 1987, 102: 1088-1095.
11Schroder DM, Chambors A, France CJ. Operative strategy for thyroid cancer. Cancer, 1986, 58: 2320- 2328.
12Harness JK, McLeod MK, Thompson NW. Death due to differentiated thyroid cancer. W J Surg, 1988, 12: 623-629.
13DeGroot L J, Kaplan EL, McCormick M. Natural history, treatment and course of papillary thyroid carcinoma. J Clin Endocrinol Metab, 1990, 71: 414-424.
14Giles Y, Boztepe H, Terzioglu T, et al. The advantage of total thyroidectomy to avoid reoperation for incidental thyroid cancer in multinodular goiter. Arch Surg, 2004;139:179-182.
15Greenblatt DY, Woltman T, Harter J, et al. Fine-Needle Aspiration Optimizes Surgical Management in Patients With Thyroid Cancer. Ann Surg Oncol, 2006 Apr 13;[Epub ahead of print]
16Köybaşıoğlu F, Özakkoyunlu S. Tiroid nodüllerinin tanısında ince iğne aspirasyon sitolojisi ve frozen kesitin değeri. Türk Otolaringoloji Arşivi, 2004;42:210-214.
17AACE/AME Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules.Endocr Pract, 2006;12:63-102.
18Dewil B, Van Damme B, Vander Poorten V, et al. Completion thyroidectomy after the unexpected diagnosis of thyroid cancer. B-ENT, 2005;1:67-72.
19Kim ES, Kim TY, Koh JM, et al. Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation. Clin Endocrinol, 2004;61:145-148.
20Kupferman ME, Mandel SJ, DiDonato L, et al. Safety of completion thyroidectomy following unilateral lobectomy for well-differentiated thyroid cancer. Laryngoscope, 2002;112:1209-12.
21Kılıç YA. Sayek İ. Tamamlayıcı tiroidektomi. In: Sayek İ. Temel Cerrahi. 3. Baskı. Ankara: Güneş Kitapevi, 2004:1617-1620.
22El-Zohairy M, Zaher A. Re-operation for the treatment of well differentiated thyroid cancer: necessity, safety and impaction on further management. J Egypt Natl Canc Inst, 2004;16:130-136.
23Pacini F, Schlumberger M, Harmer C. et al. Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report. Eur J Endocrinol, 2005;153:651-659.